Ocular Therapeutix, Inc. Stock, NASDAQ:OCUL
15 Crosby Drive, 24 Crosby Drive, Bedford, Massachusetts 01730
United States of America
Number of Employees: 161
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.